{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T01:03:49Z","timestamp":1788829429453,"version":"build-2803163510"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T00:00:00Z","timestamp":1353283200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"published-print":{"date-parts":[[2012,12]]},"DOI":"10.1186\/1748-717x-7-193","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T14:14:31Z","timestamp":1353334471000},"source":"Crossref","is-referenced-by-count":70,"title":["Definitive radiotherapy for early (T1-T2) Glottic Squamous cell carcinoma: a 20 year Cleveland clinic experience"],"prefix":"10.1186","volume":"7","author":[{"given":"Mohammad K","family":"Khan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo A","family":"Koyfman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant K","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandana A","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerrold P","family":"Saxton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,19]]},"reference":[{"key":"677_CR1","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1097\/MLG.0b013e3181781791","volume":"118","author":"T Nomiya","year":"2008","unstructured":"Nomiya T, Nemoto K, Wada H, Takai Y, Yamada S: Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma. Laryngoscope 2008, 118: 1417-1421. 10.1097\/MLG.0b013e3181781791","journal-title":"Laryngoscope"},{"key":"677_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.ijrobp.2005.10.010","volume":"64","author":"PA Groome","year":"2006","unstructured":"Groome PA, O'Sullivan B, Mackillop WJ, Jackson LD, Schulze K, Irish JC, Warde PR, Schneider KM, Mackenzie RG, Hodson DI, et al.: Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules. Int J Radiat Oncol Biol Phys 2006, 64: 1002-1012. 10.1016\/j.ijrobp.2005.10.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR3","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1016\/j.ijrobp.2005.05.013","volume":"63","author":"P Frata","year":"2005","unstructured":"Frata P, Cellai E, Magrini SM, Bonetti B, Vitali E, Tonoli S, Buglione M, Paiar F, Barca R, Fondelli S, et al.: Radical radiotherapy for early glottic cancer: results in a series of 1087 patients from two Italian radiation oncology centers. II. The case of T2N0 disease. Int J Radiat Oncol Biol Phys 2005, 63: 1387-1394. 10.1016\/j.ijrobp.2005.05.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR4","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.ijrobp.2003.08.002","volume":"58","author":"EI Cho","year":"2004","unstructured":"Cho EI, Sasaki CT, Haffty BG: Prognostic significance of pretreatment hemoglobin for local control and overall survival in T1-T2N0 larynx cancer treated with external beam radiotherapy. Int J Radiat Oncol Biol Phys 2004, 58: 1135-1140. 10.1016\/j.ijrobp.2003.08.002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR5","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/S0167-8140(03)00059-8","volume":"68","author":"RV Gowda","year":"2003","unstructured":"Gowda RV, Henk JM, Mais KL, Sykes AJ, Swindell R, Slevin NJ: Three weeks radiotherapy for T1 glottic cancer: the Christie and Royal Marsden Hospital Experience. Radiother Oncol 2003, 68: 105-111. 10.1016\/S0167-8140(03)00059-8","journal-title":"Radiother Oncol"},{"key":"677_CR6","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/S0360-3016(02)03938-X","volume":"55","author":"AS Garden","year":"2003","unstructured":"Garden AS, Forster K, Wong PF, Morrison WH, Schechter NR, Ang KK: Results of radiotherapy for T2N0 glottic carcinoma: does the \"2\" stand for twice-daily treatment? Int J Radiat Oncol Biol Phys 2003, 55: 322-328. 10.1016\/S0360-3016(02)03938-X","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/S0360-3016(98)00062-5","volume":"41","author":"P Warde","year":"1998","unstructured":"Warde P, O'Sullivan B, Bristow RG, Panzarella T, Keane TJ, Gullane PJ, Witterick IP, Payne D, Liu FF, McLean M, et al.: T1\/T2 glottic cancer managed by external beam radiotherapy: the influence of pretreatment hemoglobin on local control. Int J Radiat Oncol Biol Phys 1998, 41: 347-353. 10.1016\/S0360-3016(98)00062-5","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR8","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/S0360-3016(97)00284-8","volume":"39","author":"QT Le","year":"1997","unstructured":"Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL: Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997, 39: 115-126.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR9","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/S0360-3016(97)00150-8","volume":"38","author":"LS Burke","year":"1997","unstructured":"Burke LS, Greven KM, McGuirt WT, Case D, Hoen HM, Raben M: Definitive radiotherapy for early glottic carcinoma: prognostic factors and implications for treatment. Int J Radiat Oncol Biol Phys 1997, 38: 1001-1006. 10.1016\/S0360-3016(97)00150-8","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"677_CR10","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.ijrobp.2009.08.066","volume":"78","author":"BS Chera","year":"2010","unstructured":"Chera BS, Amdur RJ, Morris CG, Kirwan JM, Mendenhall WM: T1N0 to T2N0 Squamous Cell Carcinoma of the Glottic Larynx Treated with Definitive Radiotherapy. Int J Radiat Oncol Biol Phys 2010,78(2):461-466. 10.1016\/j.ijrobp.2009.08.066","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR11","doi-asserted-by":"publisher","first-page":"ix","DOI":"10.1007\/0-387-33126-3","volume-title":"Book AJCC cancer staging atlas (Editor ed.^eds.)","author":"FL Greene","year":"2006","unstructured":"Greene FL, American Joint Committee on Cancer: AJCC cancer staging atlas. In Book AJCC cancer staging atlas (Editor ed.^eds.). City: Springer; 2006:ix-352. ix, 352 p"},{"key":"677_CR12","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1016\/j.ijrobp.2007.05.077","volume":"69","author":"SP Reddy","year":"2007","unstructured":"Reddy SP, Hong RL, Nagda S, Emami B: Effect of tumor bulk on local control and survival of patients with T1 glottic cancer: a 30-year experience. Int J Radiat Oncol Biol Phys 2007, 69: 1389-1394. 10.1016\/j.ijrobp.2007.05.077","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR13","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.ijrobp.2006.07.1339","volume":"66","author":"AP Trotti","year":"2006","unstructured":"Trotti AP, Emami T, Hammond B, Jones E, Morrison C, Sagar W, Ridge S, Fu J, Ang K, K K: A randomized trial of hyperfractionation versus standard fractionation in T2 squamous cell carcinoma of the vocal cord. Int J Radiat Oncol Biol Phys 2006, 66: S15.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR14","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ijrobp.2005.10.003","volume":"64","author":"T Akimoto","year":"2006","unstructured":"Akimoto T, Nonaka T, Kitamoto Y, Ishikawa H, Ninomiya H, Chikamatsu K, Furuya N, Hayakawa K, Mitsuhashi N, Nakano T: Radiation therapy for T2N0 laryngeal cancer: A retrospective analysis for the impact of concurrent chemotherapy on local control. Int J Radiat Oncol Biol Phys 2006, 64: 995-1001. 10.1016\/j.ijrobp.2005.10.003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"677_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1269\/jrr.09134","volume":"51","author":"T Nonoshita","year":"2010","unstructured":"Nonoshita T, Shioyama Y, Nakamura K, Nakashima T, Ohga S, Yoshitake T, Ohnishi K, Terashima K, Asai K, Honda H: Concurrent chemoradiotherapy with S-1 for T2N0 glottic squamous cell carcinoma. J Radiat Res (Tokyo) 2010, 51: 481-484. 10.1269\/jrr.09134","journal-title":"J Radiat Res (Tokyo)"},{"key":"677_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/lary.21432","volume":"121","author":"S Misono","year":"2011","unstructured":"Misono S, Merati AL: Are patient-reported voice outcomes better after surgery or after radiation for treatment of T1 glottic carcinoma? Laryngoscope 2011, 121: 461-462. 10.1002\/lary.21432","journal-title":"Laryngoscope"},{"key":"677_CR17","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/lary.21226","volume":"121","author":"KM Higgins","year":"2011","unstructured":"Higgins KM: What treatment for early-stage glottic carcinoma among adult patients: CO2 endolaryngeal laser excision versus standard fractionated external beam radiation is superior in terms of cost utility? Laryngoscope 2011, 121: 116-134. 10.1002\/lary.21226","journal-title":"Laryngoscope"},{"issue":"3","key":"677_CR18","doi-asserted-by":"publisher","first-page":"S418","DOI":"10.1016\/j.ijrobp.2009.07.958","volume":"75","author":"MK Khan","year":"2009","unstructured":"Khan MK, Koyfman S, Hunter GH, Reddy S, Saxton JP: Outcome of Early Glottic (T1\/T2) Treated with Radiotherapy at the Cleveland Clinic Foundation: A 20 Year Experience. Int J Radiat Oncol Biol Phys 2009,75(3):S418-419.","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1748-717X-7-193\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1748-717X-7-193.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:15:09Z","timestamp":1548202509000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/1748-717X-7-193"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11,19]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["677"],"URL":"https:\/\/doi.org\/10.1186\/1748-717x-7-193","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,11,19]]},"article-number":"193"}}